These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3080895)

  • 1. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.
    Hsueh W; Gonzalez-Crussi F; Arroyave JL
    Am J Pathol; 1986 Feb; 122(2):231-9. PubMed ID: 3080895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia.
    Hsueh W; González-Crussi F; Arroyave JL
    FASEB J; 1987 Nov; 1(5):403-5. PubMed ID: 3678700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
    Dembinska-Kiec A; Peskar BA; Muller MK; Peskar BM
    Prostaglandins; 1989 Jan; 37(1):69-91. PubMed ID: 2717778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase.
    Furukawa M; Lee EL; Johnston JM
    Pediatr Res; 1993 Aug; 34(2):237-41. PubMed ID: 8233731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin and hypoxia-induced intestinal necrosis in rats: the role of platelet activating factor.
    Caplan MS; Kelly A; Hsueh W
    Pediatr Res; 1992 May; 31(5):428-34. PubMed ID: 1603619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat.
    Boughton-Smith NK; Hutcheson I; Whittle BJ
    Prostaglandins; 1989 Sep; 38(3):319-33. PubMed ID: 2506613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.
    Sun XM; Hsueh W
    J Clin Invest; 1988 May; 81(5):1328-31. PubMed ID: 3366898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor-induced vasoconstriction in rat isolated, perfused hearts: contribution of cyclo-oxygenase and lipoxygenase arachidonic acid metabolites.
    Stewart AG; Piper PJ
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():163-72. PubMed ID: 3095850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists.
    Hsueh W; Gonzalez-Crussi F; Arroyave JL; Anderson RC; Lee ML; Houlihan WJ
    Eur J Pharmacol; 1986 Apr; 123(1):79-83. PubMed ID: 3754817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor.
    Hsueh W; Gonzalez-Crussi F; Arroyave JL
    J Clin Invest; 1986 Jul; 78(1):108-14. PubMed ID: 3459734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF-induced bowel necrosis. Effects of vasodilators.
    Zhang C; Hsueh W
    Dig Dis Sci; 1991 May; 36(5):634-40. PubMed ID: 1902409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cobra venom factor, an activator of the complement system, enhances the bowel necrosis induced by platelet-activating factor.
    Llausas-Magana E; Hsueh W; Arroyave CM; Arroyave JL; Torre-Amione G; Gonzalez-Crussi F
    Immunopharmacology; 1988; 15(1):31-7. PubMed ID: 3360596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
    Stimler NP; O'Flaherty JT
    Am J Pathol; 1983 Oct; 113(1):75-84. PubMed ID: 6624879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
    Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury.
    Sun XM; Qu XW; Huang W; Granger DN; Bree M; Hsueh W
    Am J Physiol; 1996 Jan; 270(1 Pt 1):G184-90. PubMed ID: 8772517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig.
    Bonnet J; Thibaudeau D; Bessin P
    Prostaglandins; 1983 Sep; 26(3):457-66. PubMed ID: 6419289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat.
    MacKendrick W; Caplan M; Hsueh W
    Pediatr Res; 1993 Aug; 34(2):222-8. PubMed ID: 8233729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of hypotension produced by platelet-activating factor.
    Laurindo FR; Goldstein RE; Davenport NJ; Ezra D; Feuerstein GZ
    J Appl Physiol (1985); 1989 Jun; 66(6):2681-90. PubMed ID: 2745330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.